Feb
16
2022
0
Opportunities and challenges for CAR T-cell therapy in cancer
In this Review article, Soundarajan summarises the current state of chimeric antigen receptor (CAR) T-cell therapy for cancer, with a particular focus on the future opportunities and remaining challenges for this novel class of cancer therapeutics.